Viking Global Investors Lp - Net Worth and Insider Trading
Viking Global Investors Lp Net Worth
The estimated net worth of Viking Global Investors Lp is at least $5.0 Billion dollars as of 2025-04-26. Viking Global Investors Lp is the 10% Owner of Myovant Sciences Ltd and owns about 40,765,599 shares of Myovant Sciences Ltd (MYOV) stock worth over $1.1 Billion. Viking Global Investors Lp is the 10% Owner of APi Group Corp and owns about 27,032,516 shares of APi Group Corp (APG) stock worth over $1.0 Billion. Viking Global Investors Lp is also the 10% Owner of Roivant Sciences Ltd and owns about 75,238,700 shares of Roivant Sciences Ltd (ROIV) stock worth over $828 Million. Besides these, Viking Global Investors Lp also holds BridgeBio Pharma Inc (BBIO) , RayzeBio inc (RYZB) , Urovant Sciences Ltd (UROV) , Adaptive Biotechnologies Corp (ADPT) , Inhibrx Inc (INBX) , FIGS Inc (FIGS) , PROCEPT BioRobotics Corp (PRCT) , 4D Molecular Therapeutics Inc (FDMT) , Frazier Lifesciences Acquisition Corp (FLAC) , Amylyx Pharmaceuticals Inc (AMLX) , Sio Gene Therapies Inc (SIOX) , Zentalis Pharmaceuticals Inc (ZNTL) , Rallybio Corp (RLYB) . Details can be seen in Viking Global Investors Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Viking Global Investors Lp has not made any transactions after 2025-01-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Viking Global Investors Lp
Viking Global Investors Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Viking Global Investors Lp owns 22 companies in total, including Inhibrx Inc (INBX) , APi Group Corp (APG) , and Zentalis Pharmaceuticals Inc (ZNTL) among others .
Click here to see the complete history of Viking Global Investors Lp’s form 4 insider trades.
Insider Ownership Summary of Viking Global Investors Lp
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
INBX | Inhibrx Inc | 2023-08-28 | 10 percent owner |
APG | APi Group Corp | 2024-06-17 | 10 percent owner |
ZNTL | Zentalis Pharmaceuticals Inc | 2020-12-01 | 10 percent owner |
![]() | ![]() | 2020-12-14 | 10 percent owner |
![]() | ![]() | 2016-07-08 | 10 percent owner |
![]() | ![]() | 2019-03-18 | 10 percent owner |
![]() | ![]() | 2019-06-04 | 10 percent owner |
![]() | ![]() | 2019-07-10 | other: Former 10% Owner |
![]() | ![]() | 2025-01-31 | 10 percent owner |
![]() | ![]() | 2016-04-13 | 10 percent owner |
![]() | ![]() | 2016-02-02 | 10 percent owner |
![]() | ![]() | 2014-10-01 | 10 percent owner |
![]() | ![]() | 2022-03-18 | 10 percent owner |
![]() | ![]() | 2023-06-22 | 10 percent owner |
![]() | ![]() | 2024-01-04 | 10 percent owner |
![]() | ![]() | 2022-09-09 | 10 percent owner |
![]() | ![]() | 2022-11-15 | 10 percent owner |
![]() | ![]() | 2022-03-02 | 10 percent owner |
![]() | ![]() | 2021-09-03 | 10 percent owner |
![]() | ![]() | 2022-11-02 | 10 percent owner |
![]() | ![]() | 2022-11-01 | 10 percent owner |
![]() | ![]() | 2023-09-19 | 10 percent owner |
Viking Global Investors Lp Latest Holdings Summary
Viking Global Investors Lp currently owns a total of 16 stocks. Among these stocks, Viking Global Investors Lp owns 40,765,599 shares of Myovant Sciences Ltd (MYOV) as of June 4, 2019, with a value of $1.1 Billion and a weighting of 21.99%. Viking Global Investors Lp owns 27,032,516 shares of APi Group Corp (APG) as of June 17, 2024, with a value of $1.0 Billion and a weighting of 20.24%. Viking Global Investors Lp also owns 75,238,700 shares of Roivant Sciences Ltd (ROIV) as of June 22, 2023, with a value of $828 Million and a weighting of 16.56%. The other 13 stocks BridgeBio Pharma Inc (BBIO) , RayzeBio inc (RYZB) , Urovant Sciences Ltd (UROV) , Adaptive Biotechnologies Corp (ADPT) , Inhibrx Inc (INBX) , FIGS Inc (FIGS) , PROCEPT BioRobotics Corp (PRCT) , 4D Molecular Therapeutics Inc (FDMT) , Frazier Lifesciences Acquisition Corp (FLAC) , Amylyx Pharmaceuticals Inc (AMLX) , Sio Gene Therapies Inc (SIOX) , Zentalis Pharmaceuticals Inc (ZNTL) , Rallybio Corp (RLYB) have a combined weighting of 41.21% among all his current holdings.
Latest Holdings of Viking Global Investors Lp
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MYOV | Myovant Sciences Ltd | 2019-06-04 | 40,765,599 | 26.98 | 1,099,855,861 |
APG | APi Group Corp | 2024-06-17 | 27,032,516 | 37.44 | 1,012,097,399 |
ROIV | Roivant Sciences Ltd | 2023-06-22 | 75,238,700 | 11.01 | 828,378,087 |
BBIO | BridgeBio Pharma Inc | 2025-01-31 | 22,055,375 | 36.31 | 800,720,389 |
RYZB | RayzeBio inc | 2023-09-19 | 6,642,700 | 62.49 | 415,102,323 |
UROV | Urovant Sciences Ltd | 2019-06-19 | 22,860,013 | 16.24 | 371,246,611 |
ADPT | Adaptive Biotechnologies Corp | 2020-12-14 | 29,993,708 | 7.90 | 236,950,293 |
INBX | Inhibrx Inc | 2023-08-28 | 7,150,826 | 15.70 | 112,267,968 |
FIGS | FIGS Inc | 2021-09-03 | 14,742,689 | 4.04 | 59,560,464 |
PRCT | PROCEPT BioRobotics Corp | 2022-03-18 | 298,205 | 52.49 | 15,652,780 |
FDMT | 4D Molecular Therapeutics Inc | 2024-01-04 | 4,247,914 | 3.34 | 14,188,033 |
FLAC | Frazier Lifesciences Acquisition Corp | 2022-11-02 | 1,211,582 | 9.87 | 11,958,314 |
AMLX | Amylyx Pharmaceuticals Inc | 2022-09-09 | 1,850,940 | 5.36 | 9,921,038 |
SIOX | Sio Gene Therapies Inc | 2019-03-18 | 13,244,048 | 0.48 | 6,330,655 |
ZNTL | Zentalis Pharmaceuticals Inc | 2020-12-01 | 3,943,284 | 1.43 | 5,638,896 |
RLYB | Rallybio Corp | 2021-07-29 | 4,194,777 | 0.30 | 1,272,276 |
Holding Weightings of Viking Global Investors Lp
Viking Global Investors Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Viking Global Investors Lp has made a total of 0 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years. The most-recent trade in Myovant Sciences Ltd is the acquisition of 2,424,242 shares on June 4, 2019, which cost Viking Global Investors Lp around $20 Million.
According to the SEC Form 4 filings, Viking Global Investors Lp has made a total of 6 transactions in APi Group Corp (APG) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in APi Group Corp is the sale of 1,951,782 shares on June 17, 2024, which brought Viking Global Investors Lp around $74 Million.
According to the SEC Form 4 filings, Viking Global Investors Lp has made a total of 1 transactions in Roivant Sciences Ltd (ROIV) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Roivant Sciences Ltd is the sale of 13,000,000 shares on June 22, 2023, which brought Viking Global Investors Lp around $129 Million.
More details on Viking Global Investors Lp's insider transactions can be found in the Insider Trading History of Viking Global Investors Lp table.Insider Trading History of Viking Global Investors Lp
- 1
Viking Global Investors Lp Trading Performance
GuruFocus tracks the stock performance after each of Viking Global Investors Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Viking Global Investors Lp is 7.24%. GuruFocus also compares Viking Global Investors Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Viking Global Investors Lp within 3 months outperforms 17 times out of 28 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Viking Global Investors Lp's insider trading performs compared to the benchmark.
Performance of Viking Global Investors Lp
Viking Global Investors Lp Ownership Network
Ownership Network List of Viking Global Investors Lp
Ownership Network Relation of Viking Global Investors Lp

Viking Global Investors Lp Owned Company Details
What does Inhibrx Inc do?
Who are the key executives at Inhibrx Inc?
Viking Global Investors Lp is the 10 percent owner of Inhibrx Inc. Other key executives at Inhibrx Inc include director & 10 percent owner & Chief Scientific Officer Brendan P. Eckelman , 10 percent owner David C. Ott , and 10 percent owner Viking Global Opportunities Parent Gp Llc .
Inhibrx Inc (INBX) Insider Trades Summary
Over the past 18 months, Viking Global Investors Lp made no insider transaction in Inhibrx Inc (INBX). Other recent insider transactions involving Inhibrx Inc (INBX) include a net sale of 300,000 shares made by Brendan P. Eckelman ,
In summary, during the past 3 months, insiders sold 0 shares of Inhibrx Inc (INBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 300,000 shares of Inhibrx Inc (INBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 300,000 shares.
Inhibrx Inc (INBX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inhibrx Inc Insider Transactions
Viking Global Investors Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Viking Global Investors Lp. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Viking Global Investors Lp's mailing address is: Stamford Ct 06901.